Therefore, we hypothesized that high expression of aromatase may increase estrogen/ER signaling, which may be involved in the regulation of histopathological changes in the prostate of BPH patients with accelerated clinical progression. The gene discussed is CYP19A1; the disease is benign prostatic hyperplasia.